Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Gerosa

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
Journal of Autoimmunity|October 2, 2021
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohortMariele Gatto, Francesca Saccon, Laura Andreoli, et al.
The Lancet. Rheumatology|May 26, 2025
ERN ReCONNET-SLICC-SLEuro expert consensus on the therapeutic management of rare systemic lupus erythematosus manifestationsLaurent Arnaud, Guillermo Ruiz-Irastorza, Cynthia Aranow, et al.
The Lancet. Rheumatology|February 8, 2026
Patient profiles and early response in patients with systemic lupus erythematosus initiating anifrolumab: interim analysis from the ongoing multicentre observational REVEAL studyChiara Tani, Chiara Cardelli, Luca Moroni, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 11, 2020
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life SettingMariele Gatto, Francesca Saccon, Margherita Zen, et al.
Journal of Personalized Medicine|April 28, 2023
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study-Joint and Skin (BeRLiSS-JS)Margherita Zen, Mariele Gatto, Roberto Depascale, et al.
Arthritis and Rheumatism|January 4, 2012
Brief report: successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter studyMara Taraborelli, Véronique Ramoni, Antonio Brucato, et al.
Clinical Reviews in Allergy & Immunology|March 16, 2021
Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected IndividualsLaura Andreoli, Cecilia Nalli, Maria Grazia Lazzaroni, et al.
Joint Bone Spine|December 24, 2018
"Disease knowledge index" and perspectives on reproductive issues: A nationwide study on 398 women with autoimmune rheumatic diseasesLaura Andreoli, Maria Grazia Lazzaroni, Chiara Carini, et al.
RMD Open|April 25, 2024
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it studyLaura Andreoli, Maria Chiara Gerardi, Maria Gerosa, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 26, 2021
Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune DiseasesGuillermo Barturen, Sepideh Babaei, Francesc Català-Moll, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Journal of Autoimmunity|October 2, 2021
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohortMariele Gatto, Francesca Saccon, Laura Andreoli, et al.
The Lancet. Rheumatology|May 26, 2025
ERN ReCONNET-SLICC-SLEuro expert consensus on the therapeutic management of rare systemic lupus erythematosus manifestationsLaurent Arnaud, Guillermo Ruiz-Irastorza, Cynthia Aranow, et al.
The Lancet. Rheumatology|February 8, 2026
Patient profiles and early response in patients with systemic lupus erythematosus initiating anifrolumab: interim analysis from the ongoing multicentre observational REVEAL studyChiara Tani, Chiara Cardelli, Luca Moroni, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 11, 2020
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life SettingMariele Gatto, Francesca Saccon, Margherita Zen, et al.
Journal of Personalized Medicine|April 28, 2023
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study-Joint and Skin (BeRLiSS-JS)Margherita Zen, Mariele Gatto, Roberto Depascale, et al.
Arthritis and Rheumatism|January 4, 2012
Brief report: successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter studyMara Taraborelli, Véronique Ramoni, Antonio Brucato, et al.
Clinical Reviews in Allergy & Immunology|March 16, 2021
Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected IndividualsLaura Andreoli, Cecilia Nalli, Maria Grazia Lazzaroni, et al.
Joint Bone Spine|December 24, 2018
"Disease knowledge index" and perspectives on reproductive issues: A nationwide study on 398 women with autoimmune rheumatic diseasesLaura Andreoli, Maria Grazia Lazzaroni, Chiara Carini, et al.
RMD Open|April 25, 2024
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it studyLaura Andreoli, Maria Chiara Gerardi, Maria Gerosa, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 26, 2021
Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune DiseasesGuillermo Barturen, Sepideh Babaei, Francesc Català-Moll, et al.
Pageof 12